HPV-RELATED VULVAR SQUAMOUS CELL CARCINOMA
Clinical trials for HPV-RELATED VULVAR SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-RELATED VULVAR SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HPV-RELATED VULVAR SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Pronged attack tested for tough HPV cancers
Disease control OngoingThis study is testing a new combination of two drugs, TG4001 and avelumab, for people with advanced HPV-16 positive cancers that have returned or spread. The goal is to see if using these drugs together is safe and more effective at controlling the cancer than using avelumab alon…
Matched conditions: HPV-RELATED VULVAR SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Transgene • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Custom immune cells unleashed against multiple cancers in pioneering trial
Disease control OngoingThis early-stage study is testing the safety of a new, personalized cell therapy for people with advanced solid tumors that have stopped responding to standard treatments. Doctors collect a patient's own immune cells, genetically modify them to better recognize and attack their s…
Matched conditions: HPV-RELATED VULVAR SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: TScan Therapeutics, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC